Course A | Day 1 | Day 2 | Day3 | Day 4 | Day 5 | ||
Methotrexate iv (5 g/m2)1-150 | + | ||||||
Vincristine iv (2 mg) | + | ||||||
Ifosfamide iv (800 mg/m2)1-151 | + | + | + | + | |||
Dexamethasone po (10 mg/m2) | + | + | + | + | |||
Prednisolone icv (2.5 mg) | + | + | + | + | |||
Methotrexate icv (3 mg) | + | + | + | + | |||
Ara-C icv (30 mg) | + | ||||||
Course B | Day 1 | Day 2 | Day3 | Day 4 | Day 5 | ||
Methotrexate iv (5 g/m2)1-150 | + | ||||||
Vincristine iv (2 mg) | + | ||||||
Cyclophosphamide iv (200 mg/m2)1-151 | + | + | + | + | |||
Dexamethasone po (10 mg/m2) | + | + | + | + | |||
Prednisolone icv (2.5 mg) | + | + | + | + | |||
Methotrexate icv (3 mg) | + | + | + | + | |||
Ara-C icv (30 mg) | + | ||||||
Course C | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 |
Ara-C iv (3 g/m2)1-152 | + | + | |||||
Vindesine iv (5 mg) | + | ||||||
Dexamethasone po (20 mg/m2) | + | + | + | + | + | ||
Prednisolone icv (2.5 mg) | + | + | + | + | |||
Methotrexate icv (3 mg) | + | + | + | + | |||
Ara-C icv (30 mg) | + |
Sequence of courses: A1 (days 1–5), B1 (days 22–26), C1 (days 43–49); A2 (days 64–68), B2 (days 85–89), C2 (days 106–112). Cycles A to C (A1 to C1) are repeated once (A2 to C2).
↵1-150 0.5 g/m2 infusion over 30 minutes and 4.5 g/m2infusion over 23.5 hours.
↵1-151 1 hour infusion.
↵1-152 3 hour infusion.
iv=Intravenous; po=oral; icv=intraventricular.
The protocol is modified in a current phase II study:
(no intraventricular therapy at day 1 of cycles A1, B1, A2, B2; systemic MTX reduced to 3 g/m2 in patients >64 y)